Palisade Bio (STU:7NS0) Current Accrued Expense : €1.42 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Current Accrued Expense?

Palisade Bio's Current Accrued Expense for the quarter that ended in Mar. 2024 was €1.42 Mil.

Palisade Bio's quarterly Current Accrued Expense increased from Sep. 2023 (€0.41 Mil) to Dec. 2023 (€0.49 Mil) and increased from Dec. 2023 (€0.49 Mil) to Mar. 2024 (€1.42 Mil).

Palisade Bio's annual Current Accrued Expense increased from Dec. 2021 (€0.24 Mil) to Dec. 2022 (€0.31 Mil) and increased from Dec. 2022 (€0.31 Mil) to Dec. 2023 (€0.49 Mil).

Palisade Bio Current Accrued Expense Historical Data

The historical data trend for Palisade Bio's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Current Accrued Expense Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

1.42

0.24

0.31

0.49

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial											0.22	0.21	0.41	0.49	1.42

Palisade Bio Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Palisade Bio Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Palisade Bio's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio (STU:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

PALI:USA 7NS:Germany

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines